Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
Abcema, abdomen, abiraterone, ADT, affinity, aforementioned, amplification, Amsterdam, antiandrogen, API, archived, armpit, ASC, ATMP, Atrophy, Baxalta, bicalutamide, Bispecific, biweekly, blockade, brain, Breyanzi, BTD, Bulbar, Byrd, CAR, carcinoma, Carvykti, CE, Celularity, Chase, checkpoint, CJEU, classical, clock, compliant, constantly, constitutionality, Council, credibility, CRL, crystallized, CTR, curative, curve, CyCART, CYNK, DAARI, database, delegated, dihydrotestosterone, dismal, display, double, dual, economy, elapsed, endometrial, endorsement, England, enlarged, Epidemiology, epithelial, expiry, explain, fullest, gastrointestinal, GB, greatest, grew, groin, harder, hinge, Houston, HSPC, IAS, image, IMPD, Importantly, inflammatory, instructed, intact, intensified, intensify, interfering, invoice, invoiced, IVDD, IVDR, justification, Krishnan, landlord, landmark, LBD, Leavitt, lesion, leverage, LnCAP, loading, luminal, lymphatic, marker, MDVR, mediated, middle, multidisciplinary, mutant, NCCN, neck, Network, neutrophil, NHL, night, NK, nmCRPC, nonrefundable, NTD, Nubeqa, outpatient, Parent, parental, Parliament, paucity, pharmacovigilance, piece, placental, Plot, portal, postmarketing, preapproval, Precigen, prepayment, PRIME, proactive, proliferative, propagated, purport, RAI, Raj, reevaluation, relocation, Representation, safest, Salim, SBMA, Schematic, Scotland, SEER, Shire, skin, SLL, sm, sparing, Spinal, sponsorship, subtype, suitability, suitable, swelling, Swimmer, synergize, TCA, testosterone, TGI, thirteen, threat, threshold, thyroid, TM, tract, translate, transposed, Ukraine, unbilled, uncontrollably, underserved, unemployment, uneven, unexplained, unlimited, unnecessary, USPI, VCaP, vehicle, vigilance, vigilant, wholesale, Yazji, zilovertamab
Removed:
acquirer, allocated, alopecia, antagonize, attributable, ceased, closed, commerce, consult, degrade, discontinuing, effected, enobosarm, ER, estrogen, feature, fractional, HHS, incontinence, induce, instrument, judge, language, mechanistic, minimal, prospectively, provisional, reducing, repealed, repealing, replaced, resolution, rulemaking, split, SUI, TNBC, Trump, unconstitutional, unvested, urge, urinary, vested
Filing tables
Filing exhibits
Related press release
Associated ONCT transcripts
ONCT similar filings
Filing view
External links
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
Oncternal Therapeutics, Inc.
San Diego, California
We hereby consent to the incorporation by reference in the Registration Statements on Form S-3 (Nos. 333-221040, 333-204932, 333-201132, 333-197911, and 333-254985) and Form S-8 (Nos. 333-233288, 333-223742, 333-210220, 333-208744, 333-188377, 333-165507, 333-149661, 333-136527, 333-118882, 333-112576 and 333-254581) of Oncternal Therapeutics, Inc., of our report dated March 10, 2022, relating to the consolidated financial statements, which appears in this annual report on Form 10-K.
/s/ BDO USA, LLP
San Diego, California
March 10, 2022